Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial - The Lancet
JCI - Results of the CAPSID randomized trial for high-dose convalescent plasma in patients with severe COVID-19
UK launches booster dose trial of seven Covid-19 vaccines
The phases of preclinical and clinical trials
Dose-Levels and First Signs of Efficacy in Contemporary Oncology Phase 1 Clinical Trials | PLOS ONE
Ponatinib dose-ranging study in chronic-phase chronic myeloid leukemia: a randomized, open-label phase 2 clinical trial - ScienceDirect
Dose escalation design for the Part 1 of the trial. Single patients... | Download Scientific Diagram
Diuretic Strategies in Patients with Acute Decompensated Heart Failure | NEJM
Clinical and Pharmacological Effects of Apixaban Dose Adjustment in the ARISTOTLE Trial | Journal of the American College of Cardiology
PureTech Presents Data for LYT-100 (Deupirfenidone) Supporting Design of Dose-Ranging Trial in Idiopathic Pulmonary Fibrosis (IPF) at European Respiratory Society International Congress 2022 | Business Wire
Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial - The Lancet
Vaccines | Free Full-Text | The Correlated Beta Dose Optimisation Approach: Optimal Vaccine Dosing Using Mathematical Modelling and Adaptive Trial Design
Diuretic Strategies in Patients with Acute Decompensated Heart Failure | NEJM
The future of drug development: advancing clinical trial design | Nature Reviews Drug Discovery
Trial Design Including Dose Escalation and Treatment Schedule 2a)... | Download Scientific Diagram
DESTINY-Lung02 Trial | ENHERTU® (fam-trastuzumab deruxtecan-nxki)
Safety and tolerability of bosutinib in patients with amyotrophic lateral sclerosis (iDReAM study): A multicentre, open-label, dose-escalation phase 1 trial - eClinicalMedicine
فدوى الخريصي on Twitter: "The Dose Trial 💉 https://t.co/jnw6hmKvqr" / Twitter
Phase 1A/1B dose-escalation and -expansion study to evaluate the safety, pharmacokinetics, food effects and antitumor activity of pamiparib in advanced solid tumours | British Journal of Cancer
A phase I, randomized, observer-blinded, single and multiple ascending-dose study to investigate the safety, pharmacokinetics, and immunogenicity of BITS7201A, a bispecific antibody targeting IL-13 and IL-17, in healthy volunteers | BMC Pulmonary
Diuretic Strategies in Patients with Acute Decompensated Heart Failure - ppt download
The phases of preclinical and clinical trials
Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients | NEJM
How a COVID-19 vaccine trial error led to an unexpected discovery
How to design a dose-finding study using the continual reassessment method | BMC Medical Research Methodology | Full Text
